YBX1 and melanoma: Immunofluorescent staining of vemurafenib resistant melanoma cells revealed particularly high levels of S102-phosphorylated YB-1 during the mitotic phase with predominant localization at the spindle apparatus, suggesting an increased RSK activity during this part of the cell cycle (Figure 3A, 3B).